Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (10) , 1793-1800
- https://doi.org/10.1016/j.jacc.2003.05.011
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care settingJournal of the American College of Cardiology, 2001
- Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the communityHeart, 2000
- Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational studyBMJ, 2000
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Identification, Diagnosis and Treatment of Heart Failure: Could We Do Better?Cardiology, 1996
- The Amino-Terminal Portion of Pro-Brain Natriuretic Peptide (Pro-BNP) Circulates in Human PlasmaBiochemical and Biophysical Research Communications, 1995
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failureClinical Science, 1992